Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The history of breast cancer diagnosis

Prof László Tabár - University of Uppsala, Uppsala, Sweden
The history of breast cancer diagnosis ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )
29 Jan 2021

Recent therapies for HER2 advanced breast cancer

Dr Sandra Swain - Georgetown University, Washington DC, USA
Recent therapies for HER2 advanced breast cancer ( Dr Sandra Swain - Georgetown University, Washington DC, USA )
29 Jan 2021

BRCA mutation in metastatic TNBC patients

Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon
BRCA mutation in metastatic TNBC patients ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )
28 Jan 2021

The role of immune checkpoint inhibitors in NSCLC

Dr Maurice Pérol, Centre Léon Bérard, Lyon, France
The role of immune checkpoint inhibitors in NSCLC ( Dr Maurice Pérol, Centre Léon Bérard, Lyon, France )
27 Jan 2021

OncoAlert and ecancer weekly roundup for January 18 - 24, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for January 18 - 24, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
25 Jan 2021

OncoAlert and ecancer weekly roundup for January 11 - 17, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for January 11 - 17, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
21 Jan 2021

Ferroptosis regulator as a novel therapeutic target for STK11/KEAP1 co-mutant lung adenocarcinoma

Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA
Ferroptosis regulator as a novel therapeutic target for STK11/KEAP1 co-mutant lung adenocarcinoma ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA )
20 Jan 2021

The biology and therapeutic options for STK11/KEAP1 co-mutant lung adenocarcinoma

Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA
The biology and therapeutic options for STK11/KEAP1 co-mutant lung adenocarcinoma ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA )
20 Jan 2021

The importance of Romanian oncology congress 2020

Dr Dana Stanculeanu Stănculeanu - Institute of Oncology Bucharest, Romania
The importance of Romanian oncology congress 2020 ( Dr Dana Stanculeanu Stănculeanu - Institute of Oncology Bucharest, Romania )
19 Jan 2021

Advances and challenges in treating melanoma and breast cancer in Romania

Dr Daniela Zob - Institute of Oncology, Bucharest, Romania
Advances and challenges in treating melanoma and breast cancer in Romania ( Dr Daniela Zob - Institute of Oncology, Bucharest, Romania )
18 Jan 2021

Latest in non-small cell lung cancer pathology

Prof Benjamin Besse and Prof Albrecht Stenzinger
Latest in non-small cell lung cancer pathology ( Prof Benjamin Besse and Prof Albrecht Stenzinger )
6 Jan 2021

The use of PARP inhibitors in oncology from a palliative care perspective

Judy Knudson, PA-C - University of Colorado, Denver, USA
The use of PARP inhibitors in oncology from a palliative care perspective ( Judy Knudson, PA-C - University of Colorado, Denver, USA )
24 Dec 2020